Jenny Hsieh
Corporate Officer/Principal bei ACTINIUM PHARMACEUTICALS, INC.
Profil
Jenny Hsieh is currently the Chief Strategy Officer at Actinium Pharmaceuticals, Inc. She previously worked as the Director of Corporate Strategy at Quest Diagnostics, Inc. and as the Head of Corporate Strategy at Immunomedics, Inc. Hsieh received an undergraduate degree from the University of Pennsylvania and an MBA from The Leonard N Stern School of Business.
Aktive Positionen von Jenny Hsieh
| Unternehmen | Position | Beginn |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Jenny Hsieh
| Unternehmen | Position | Ende |
|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED | Corporate Officer/Principal | - |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Jenny Hsieh
| University of Pennsylvania | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| QUEST DIAGNOSTICS INCORPORATED | Health Services |
| Private Unternehmen | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
